Literature DB >> 16649014

[Recombinant activated factor VIIa for treatment of traumatic liver rupture].

W Leidinger1, J N Meierhofer, R Woelfel.   

Abstract

Hepatic rupture after blunt abdominal trauma may lead to severe bleeding, depletion and consumption of clotting factors, with the risk of packing to defer the definitive operation. We report two cases of hepatic rupture after blunt trauma with intrahepatic hematoma and severe intraabdominal bleeding. In both cases the bleeding could be stopped by early intervention with recombinant activated factor VIIa (rFVIIa). In neither case was surgical intervention necessary and after 3 weeks both patients were released without complications. These cases demonstrate that the early therapy with a single dose of rFVIIa before the development of a hemostatic crisis is a therapeutic option in selected cases where surgical therapy of the bleeding is difficult and risky.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16649014     DOI: 10.1007/s00101-006-1032-5

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  23 in total

Review 1.  [Surgical management of liver rupture].

Authors:  F Safi; S Weiner; B Poch; A Schwarz; H G Beger
Journal:  Chirurg       Date:  1999-03       Impact factor: 0.955

2.  Early coagulopathy predicts mortality in trauma.

Authors:  Jana B A MacLeod; Mauricio Lynn; Mark G McKenney; Stephen M Cohn; Mary Murtha
Journal:  J Trauma       Date:  2003-07

3.  Early injection of high-dose recombinant factor VIIa decreases blood loss and prolongs time from injury to death in experimental liver injury.

Authors:  Igor Jeroukhimov; Dory Jewelewicz; Julia Zaias; George Hensley; Jana MacLeod; Stephen M Cohn; Qammar Rashid; Francisco Pernas; Marlies R Ledford; Eleanor Gomez-Fein; Mauricio Lynn
Journal:  J Trauma       Date:  2002-12

4.  Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials.

Authors:  Kenneth David Boffard; Bruno Riou; Brian Warren; Philip Iau Tsau Choong; Sandro Rizoli; Rolf Rossaint; Mads Axelsen; Yoram Kluger
Journal:  J Trauma       Date:  2005-07

5.  Organ injury scaling: spleen and liver (1994 revision).

Authors:  E E Moore; T H Cogbill; G J Jurkovich; S R Shackford; M A Malangoni; H R Champion
Journal:  J Trauma       Date:  1995-03

6.  Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.

Authors:  U Martinowitz; M Michaelson
Journal:  J Thromb Haemost       Date:  2005-04       Impact factor: 5.824

7.  Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.

Authors:  Jarosław Daniloś; Andrzej Goral; Piotr Paluszkiewicz; Krzysztof Przesmycki; Jan Kotarski
Journal:  Obstet Gynecol       Date:  2003-06       Impact factor: 7.661

8.  [Surgical management, prognostic factors, and outcome in hepatic trauma].

Authors:  R Ott; M R Schön; S Seidel; E Schuster; C Josten; J Hauss
Journal:  Unfallchirurg       Date:  2005-02       Impact factor: 1.000

9.  Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis.

Authors:  Gary E Hill; William H Frawley; Karl E Griffith; John E Forestner; Joseph P Minei
Journal:  J Trauma       Date:  2003-05

10.  The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients.

Authors:  Zhi Hong Meng; Alisa S Wolberg; Dougald M Monroe; Maureane Hoffman
Journal:  J Trauma       Date:  2003-11
View more
  1 in total

1.  [Hepatic trauma. Interventional and conservative therapy].

Authors:  M Loss; N Zorger; G I Kirchner; H J Schlitt
Journal:  Chirurg       Date:  2009-10       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.